| 摘要 |
<p>Thalidomide analog compounds having a general structure (I) are described. R1 is selected from a group comprising of hydroxy, hydrogen, and amine. Also described is a method for treating vascular abnormalities, such as neovascularization and vascular leakage. A therapeutically effective amount of a composition containing the thalidomide analog compound is administered to a patient. The composition may further include agents, such as solubilizing agents, inert fillers, diluents, excipients, or flavoring agents.</p> |
